Get quick answers to some commonly asked questions about our DRAP-licensed pharmacovigilance services in Pakistan.
Patient safety comes first in every clinical trial. And that’s where pharmacovigilance plays a vital role. Therefore, with a team trained according to U.S. standards, Minerva Research Solutions offers complete pharmacovigilance services in Pakistan. We detect, manage, and report adverse events accurately and on time. Moreover, our services follow DRAP pharmacovigilance compliance standards and are tailored to meet both international and local expectations.
Whether you’re a global sponsor expanding into Pakistan or a local company aiming to meet international safety benchmarks, our drug safety services in Pakistan help protect patient well-being and keep your study on track.
